Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jul-Aug;31(4):e465-e468.
doi: 10.1097/MJT.0000000000001674.

Delayed Pembrolizumab-Associated Sarcoidosis

Affiliations
Case Reports

Delayed Pembrolizumab-Associated Sarcoidosis

Srijan Valasapalli et al. Am J Ther. 2024 Jul-Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Johnson DB, Chandra S, Sosman JA. Immune checkpoint inhibitor toxicity in 2018. JAMA. 2018;320:1702–1703.
    1. Naidoo J, Page DB, Li BT, et al. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol. 2015;26:2375–2391.
    1. Muntyanu A, Netchiporouk E, Gerstein W, et al. Cutaneous immune-related adverse events (irAEs) to immune checkpoint inhibitors: a dermatology perspective on management. J Cutan Med Surg. 2021;25:59–76.
    1. Goldinger SM, Stieger P, Meier B, et al. Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy. Clin Cancer Res. 2016;22:4023–4029.
    1. Cornejo CM, Haun P, English J, et al. Immune checkpoint inhibitors and the development of granulomatous reactions. J Am Acad Dermatol. 2019;81:1165–1175.

MeSH terms

Substances

LinkOut - more resources